Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958412 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
A Phase 2 study, sponsored by Repros Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00958412 is a Phase 2 study that was terminated before completion, run by Repros Therapeutics. The registered enrollment target is 18 participants.
The verdict
NCT00958412, a Phase 2 study, was terminated before completion, sponsored by Repros Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
ZPE-201 Extension of treatment
Interventions
- DRUG Proellex®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-02-28 |
| Est. Completion | 2009-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958412
The ClinicalTrials.gov registry entry for NCT00958412 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Repros Therapeutics, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proellex® is the first listed.
NCT00958412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958412 about?
NCT00958412 is a clinical study titled "Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study". ZPE-201 Extension of treatment
What is the current status of trial NCT00958412?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2009-02-28. Estimated completion is 2009-08-31.
What interventions are being tested in trial NCT00958412?
The interventions under investigation include: Proellex® (DRUG).
Who is sponsoring clinical trial NCT00958412?
This trial is sponsored by Repros Therapeutics, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.